Żuk M, Sumriy SK, Zhuk OV. Elimination kinetics of synthetic interferon inducer tilorone in experimental animals. J Pre-Clin Clin Res. 2017; 11(2) 3 H]-I in rats and mice was studied following a single oral and intravenous administration. The excretion mass balance was monitored in the faeces and urine of rats and mice for 5 and 10 days, respectively. Radioactivity was determined in the samples of excreta using a liquid scintillation counter.
INTRODUCTION
Tilorone (trade name Amixin IC) is a broad-spectrum antiviral drug with a polymodal mechanism of action that includes direct inhibition of viral replication in infected cells and stimulation of interferon production [1] [2] [3] [4] [5] [6] . It is one of the first effective low molecular weight interferon inducers with anticancer activity [7] [8] [9] . Numerous studies have demonstrated the efficacy of tilorone in treating many viral infections, as well as conditions accompanied by weakened immune system defences [10] [11] [12] . Tilorone pharmacokinetics have not been extensively studied. The first such study that addressed the distribution of tilorone in mice at a single time point following oral administration was published in 1973 [1, 13] . The authors of the presented study have recently published a more detailed study of the metabolism and distribution of tilorone after intravenous and oral administration in mice, which demonstrated that tilorone does not undergo significant biotransformation in the body [14, 15] . The absolute bioavailability of tilorone amounted to circa 70% following oral administration, as 21% of the administered drug underwent pre-systemic elimination in the liver. The pulmonary first-pass effect was observed after intravenous injection of tilorone [15] . The equilibrium distribution ratio of substance between a tissue and blood was higher than unity, indicating the rapid distribution of tilorone into organ tissues. Irreversible binding of 1-2% of the total administered drug by the spleen was also noted [15] . Golovenko et al. studied the distribution of the total radioactivity after multiple oral doses of [ 3 H]-tilorone [16] . A high concentration of the drug in mice over 10 days of the experiment and a slow rate of elimination was shown.
The aim of this investigation was to study [ 3 H]-tilorone excretion in mice and rats following a single administration of the drug.
MATERIALS AND METHOD
This study used labeled 2,7-bis- [2- ]-I at a dose of 50 mg/kg by oral gavage. The dosing volume was 10 ml/kg for the mouse and 20 ml/kg for the rat. The oral dose was dissolved in an isotonic solution. Following gavage, the rat and mice were housed individually in metabolism cages (Tecniplast, Varese, Italy) with free access to food and water throughout the experiments. Urine and faeces samples were collected daily from rats and mice for 5 and 10 days postdosing, respectively (this time period was chosen because previous studies have shown a slow speed of the process of elimination of tilorones in the mice) [15] . Urine volume was measured, and samples were stored at −18 °C until analysis. Faeces were air-dried, weighed, and ground to a fine powder before dissolving. About 100 mg nanopure was added to the sample of formic acid (2 ml), and the mixture was left in the shaker for 24 h until thorough dissolution.
Radioactivity was determined in the samples of excreta using a Tri Carb 2700 liquid scintillation counter (Canberra Packard, USA).
Pharmacokinetic analysis.
The following pharmacokinetic parameters were calculated for tilorone: elimination rate constant (k el ), half-life in elimination phase (t 1/2 ), MRT, and the amount of drug eliminated from the body over an infinitely long experimental period (A 0-∞ ); in order to determine such fractional elimination parameters, regression analysis by a modified "rate-quantity" method was utilized, described in earlier studies [17] , and using validated software PKSolver [18] . This was based on the use of the integrated analog of the basic equation of the method and its further transformation to adapt to reproof poly exponential kinetics of xenobiotics excretion. This enabled determination of the total quantity of the drug eliminated from the body in conditions of infinite exposure (A 0-∞ ) and the constant elimination (k el ) using regression analysis on the basis of the following equations:
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Statistical analysis.
All average values are given as mean ± SD. Values of total radioactivity in excretes of mice and rats were compiled with the Student's t-test for unpaired data. The acceptable probability for a significant difference was p<0.05.
RESULTS

Elimination of [
3 Н]-tilorone in rats. In rats, almost 80% of [ 3 Н] total radioactivity was excreted in faeces and urine over the course of 120 h postdose. The principal route of tilorone elimination in rats was faecal, as it mediated excretion of about 69% of the total administered dose during the first 5 days after administration of the drug. Urinary excretion in rats was a steady-state process characterized by a slow elimination rate. In the first 120 h postdose, 10% of the total administered dose was eliminated via the renal route. The efficiency of [ 3 Н]-tilorone excretion in faeces was 7-fold higher than in urine in rats (Fig. 1) ; thus, overall elimination is mainly determined by the parameters of faecal excretion. The maximum radioactivity elimination rate from the body was observed in the first 72 h post-dose.
Overall elimination and faecal excretion in particular were biphasic with a rapid phase (0-72 h) responsible for elimination of 62-68% of the drug and slow phase (72-120 h) mediating excretion of 8-11% of the total administered dose. The urinary elimination rate was slow and mono-exponential throughout the whole period of the study.
The kinetics of the overall elimination and faecal excretion in rats could be described by a classic 2-compartment model. Corresponding kinetic parameters are given in Tab. 1. Elimination half-time was 21 h post-dose in the rapid phase, while the remaining radioactivity (~4-7% of the total administered dose) had a longer elimination halflife of about 150 h.
Elimination of [ 3 Н]-tilorone in mice.
A characteristic feature of tilorone metabolism in mice was a slower elimination rate compared to rats, as only 57.35% of the oral administered dose was eliminated in total within 10 days. Also, in contrast to observations in rats, the efficacy of excretion in urine and faeces was similar: 27.85% and 26.45% of the administered oral dose, respectively (Tab. 2). Elimination kinetics in urine and faeces were not parallel as the elimination via the renal route was almost 2-fold higher than in faeces. Regardless of the route of administration of the examined substance, the process of excretion in the urine and faeces in mice is almost equally effective. Average excretion of [ 3 H]-I for a 10-day period in case of intravenous administration was 28.9±0.24% in urine, and in faeces -24.5±0.48% of the administered dose. After 240 h of substance application, only 52.68±0.39% of the administered dose was excreted in urine and faeces (Tab. 3).
As equation (1) displays, irrespective of the species (mouse or rat), experimental data are strictly linear in these coordinates (Fig. 2) ; therefore, parameters of elimination can be determined without decomposition of the kinetic model.
The elimination rate of tilorone and its metabolites in rats is significantly dependent on the excretion route: renal k el value, as determined from the tangent of the slope angle, is 3 times lower than the faecal k el value. Elimination half-time equaled 22 and 67 h post-dose, respectively. A similar pattern was observed for the total value of eliminated tilorone and its metabolites under infinite exposure (A 0-∞ = 69% with faeces and 12% with urine).
In contrast, the elimination of tilorone in mice under oral administration was nearly identical via the renal and faecal routes, and overall fairly slow (Fig. 2) . The half-life of time of elimination (t 1/2 ) in urine was 110 ± 5.02 h after oral administration, while after intravenous administration, it was significantly lower t 1/2 = 85.57 ± 1.88 h (p ≤ 0.05). t 1/2 in the case of intestinal and hepatic excretion -97.62 ± 7.85 and 85.57 ± 3.65 h, respectively. In infinite exposure, the amount of total radioactivity excreted was 32-36% in the case of oral administration, and 25-35% in the case of intravenous dosing.
Having determined the values of k el and A 0-∞ by linear regression, it is possible to use them for the calculation of MRT. MRT value can be determined from the crossing point of the plot line with ordinate and abscissa in accordance with Equation 2 (linear anamorphosis using the value of (Fig. 3) . According to this method, the calculated values are presented in Table 4 . The method proposed by the authors allowed highly linearized sets of experimental data to be obtained, as evidenced by the tangent of the slope angle equal to unity in Figure 3 . MRT values were 140-150 h in mice, reflecting a slower elimination rate. Only 66% of the oral administered drug was excreted in conditions of infinite exposure. Intravenous 
DISCUSSION
This paper presents the comparative examination of the process of tilorone excretion in rats and mice after a single administration (oral and intravenous). Significant differences were demonstrated in the effectiveness of the excretion processes in urine and faeces in the experimental animals. Faecal elimination in rats is of a 2-phase character constituted 69% of the administered dose, whereas the process of excretion in urine (about 10%) was stationary during the whole period of examination. During 5 days of the experiment, almost the entire administered dose was excreted from the rat's organism (~90%) (Tab. 1, 4). In the case of mice, irrespective of the route of administration of [
3 H]-I, a slow elimination process was observed in the organism, and mathematical calculations demonstrated that only 60% of the administered dose in an infinite exposition was excreted from the organism of the examined animals. On examination of the distribution processes, it was inferred that the process of irreversible binding to the spleen may explain the extremely slow excretion in urine and faeces and that only 70% of the administered dose is eliminated in case of infinite exposure. It is interesting to note that the route of administration of [ 3 H]-I to mice has an insignificant effect on the kinetic parameters of excretion -the amount of excreted drug was the same, and the elimination process rate after intravenous administration insignificantly higher. Previous studies on tilorone metabolism by the authors of this study showed that this drug undergoes little biotransformation in rodents [13,15,19,] . Around 89% of the drug is eliminated in its original, parent compound form in the faeces of rats and mice. Two minor metabolites resulting from oxidation of aliphatic ends of the tilorone molecule were observed in urine [14, 19] .
The presented data show no significant differences in metabolic processes of tilorone in rats and mice, and the data give no grounds for explaining the differences in the process of its excretion.
Currently, the literature does not provide any research data concerning the processes of tilorone distribution in rats, leading to no possibility of an evaluation of the relationship between these processes and the processes of the excretion of the examined substance. Perhaps the results of future studies of tilorone distribution in rats will help explain the differences in the kinetics of tilorone elimination from the rats and mice.
MRT calculation using multi-compartmental models or models in which processes with various constant rates may be distinguished is very complex; therefore, a new mathematical model based on non-compartmental modeling and regression analysis was applied that allowed the precise calculation of the examined parameters. MRT calculations in accordance with the software PKSolver showed comparable values with the parameters calculated using the authors' proposed modification of the 'rate-quantity' method (Tab. 4). Table 4 . Kinetic parameters for elimination of total radioactive material in excreta of rats and mice after a single administration of 
